Prista Charuworn M.D., joined Zai Lab in September 2024 as Vice President, Global Clinical Development, Neuroscience & Immunology (NSI).
Dr. Charuworn is an accomplished gastroenterologist with extensive experience and leadership in clinical development and global product strategy. At Zai Lab, she is responsible for leading and advancing the research and development strategy for the company’s immunology therapeutic area, as well as its neuroscience and infectious disease assets.
Prior to joining Zai Lab, Dr. Charuworn served as Executive Medical Director, Global Development, Inflammation at Amgen. Previously, she held key leadership roles in clinical development at AstraZeneca and Gilead.
Dr. Charuworn completed her internships and residency in internal medicine and fellowship at Stanford University Medical Center. She received an M.D. from the University of California, Irvine and a B.S. in Biology from the California Institute of Technology.
